Comparator TIV

BIOLOGICAL2 trials

Sponsors

Novartis Vaccines, Novavax

Conditions

InfluenzaSeasonal Influenza

Phase 2

Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

CompletedNCT02307851

NovavaxInfluenza

Start: 2014-11-30End: 2015-06-30Updated: 2016-09-23

Phase 3

Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age

CompletedNCT01209780

Novartis VaccinesSeasonal Influenza

Start: 2010-09-30End: 2011-09-30Updated: 2014-03-11